Kiniksa Pharmaceuticals International, plc — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Paolini John F. | CHIEF MEDICAL OFFICER | Sale | 200 | $27.00 | $5,400 | 57,403 | May 7, 2025 |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | Option Exercise | 14,420 | $11.97 | $172,607 | 50,193 | May 7, 2025 |
| Moat Ross | CHIEF COMMERCIAL OFFICER | Option Exercise | 6,272 | $17.76 | $111,391 | 15,687 | May 2, 2025 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sale | 25,141 | $27.80 | $698,920 | 27,009 | May 1, 2025 |
| Moat Ross | CHIEF COMMERCIAL OFFICER | Sale | 64,035 | $25.21 | $1,614,322 | 9,415 | Apr 29, 2025 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Option Exercise | 990 | — | — | 27,488 | Apr 26, 2025 |
| Moat Ross | CHIEF COMMERCIAL OFFICER | Sale | 18,259 | $20.29 | $370,475 | 9,415 | Apr 21, 2025 |
| Tessari Eben | CHIEF OPERATING OFFICER | Sale | 6,421 | $20.74 | $133,172 | 77,363 | Apr 14, 2025 |
| Tessari Eben | CHIEF OPERATING OFFICER | Tax Withholding | 801 | $20.28 | $16,244 | 82,363 | Apr 7, 2025 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Tax Withholding | 1,303 | $20.28 | $26,425 | 26,498 | Apr 7, 2025 |
| Patel Sanj K | CHAIRMAN & CEO | Tax Withholding | 4,832 | $20.28 | $97,993 | 96,674 | Apr 7, 2025 |
| Paolini John F. | CHIEF MEDICAL OFFICER | Option Exercise | 2,498 | — | — | 58,137 | Apr 7, 2025 |
| Moat Ross | CHIEF COMMERCIAL OFFICER | Tax Withholding | 727 | $20.28 | $14,744 | 27,674 | Apr 7, 2025 |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | Option Exercise | 3,933 | — | — | 34,212 | Apr 7, 2025 |
| Moat Ross | CHIEF COMMERCIAL OFFICER | Option Exercise | 1,611 | — | — | 25,167 | Apr 1, 2025 |
| Paolini John F. | CHIEF MEDICAL OFFICER | Option Exercise | 1,624 | — | — | 54,880 | Apr 1, 2025 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Tax Withholding | 847 | $21.77 | $18,439 | 25,877 | Apr 1, 2025 |
| Tessari Eben | CHIEF OPERATING OFFICER | Option Exercise | 1,773 | — | — | 79,726 | Apr 1, 2025 |
| Patel Sanj K | CHAIRMAN & CEO | Option Exercise | 6,481 | — | — | 90,597 | Apr 1, 2025 |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | Option Exercise | 2,363 | — | — | 32,363 | Apr 1, 2025 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sale | 15,944 | $23.11 | $368,466 | 23,382 | Mar 20, 2025 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Option Exercise | 11,464 | $12.97 | $148,688 | 34,846 | Mar 16, 2025 |
| Tessari Eben | CHIEF OPERATING OFFICER | Option Exercise | 1,964 | — | — | 78,530 | Mar 16, 2025 |
| Patel Sanj K | CHAIRMAN & CEO | Option Exercise | 6,569 | — | — | 86,120 | Mar 16, 2025 |
| Paolini John F. | CHIEF MEDICAL OFFICER | Tax Withholding | 507 | $22.61 | $11,463 | 53,256 | Mar 16, 2025 |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | Sale | 9,051 | $22.45 | $203,195 | 26,528 | Mar 12, 2025 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Option Exercise | 36,372 | $11.97 | $435,373 | 59,330 | Mar 12, 2025 |
| Tessari Eben | CHIEF OPERATING OFFICER | Option Exercise | 7,000 | $3.80 | $26,600 | 88,975 | Mar 10, 2025 |
| Tessari Eben | CHIEF OPERATING OFFICER | Sale | 14,000 | $19.57 | $273,980 | 81,975 | Feb 10, 2025 |
| Moat Ross | CHIEF COMMERCIAL OFFICER | Option Exercise | 994 | — | — | 23,848 | Jan 15, 2025 |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | Tax Withholding | 328 | $22.61 | $7,416 | 27,443 | Jan 15, 2025 |
| Tessari Eben | CHIEF OPERATING OFFICER | Sale | 12,323 | $18.13 | $223,416 | 90,652 | Jan 13, 2025 |
| Tessari Eben | CHIEF OPERATING OFFICER | Sale | 23,017 | $20.44 | $470,467 | 95,975 | Dec 16, 2024 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Sale | 8,969 | $21.27 | $190,771 | 22,958 | Dec 6, 2024 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Option Exercise | 1,123 | $10.76 | $12,083 | 24,081 | Dec 4, 2024 |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | Sale | 8,637 | $22.45 | $193,901 | 26,528 | Nov 29, 2024 |
| Tessari Eben | CHIEF OPERATING OFFICER | Option Exercise | 10,000 | $1.59 | $15,900 | 119,975 | Nov 18, 2024 |
| Levy Richard S | — | Option Exercise | 1,303 | — | — | 14,200 | Nov 7, 2024 |
| Patel Sanj K | CHAIRMAN & CEO | Sale | 89,561 | $23.00 | $2,059,903 | 79,551 | Nov 6, 2024 |
| Tessari Eben | CHIEF OPERATING OFFICER | Option Exercise | 10,000 | $1.59 | $15,900 | 126,975 | Oct 15, 2024 |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | Tax Withholding | 82 | $24.48 | $2,007 | 26,528 | Oct 4, 2024 |
| Baker Brothers Life Sciences LP | — | Award / Grant | 4,730 | — | — | 2,730,419 | Oct 4, 2024 |
| Tessari Eben | CHIEF OPERATING OFFICER | Option Exercise | 10,000 | $1.59 | $15,900 | 134,475 | Sep 23, 2024 |
| Tessari Eben | CHIEF OPERATING OFFICER | Option Exercise | 1,964 | — | — | 125,052 | Sep 2, 2024 |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | Tax Withholding | 2,755 | $26.74 | $73,669 | 25,989 | Sep 1, 2024 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | Option Exercise | 1,861 | — | — | 23,914 | Sep 1, 2024 |
| Patel Sanj K | CHAIRMAN & CEO | Tax Withholding | 7,967 | $26.74 | $213,038 | 76,159 | Sep 1, 2024 |
| Paolini John F. | CHIEF MEDICAL OFFICER | Option Exercise | 60,217 | $1.86 | $112,004 | 112,255 | Sep 1, 2024 |
| Tessari Eben | CHIEF OPERATING OFFICER | Option Exercise | 10,000 | $1.59 | $15,900 | 137,411 | Aug 27, 2024 |
| Patel Sanj K | CHAIRMAN & CEO | Sale | 50,000 | $25.05 | $1,252,500 | 126,061 | Jul 23, 2024 |